Close

AcelRx Pharma (ACRX) to Present Data from Phase 3 SAP302 Study of ARX-04 as Pain Treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. GOOGL


Go back to AcelRx Pharma (ACRX) to Present Data from Phase 3 SAP302 Study of ARX-04 as Pain Treatment